Patient, prescriber and procurement behave nothing alike.
Pharmaceutical UX/UI design for interfaces serving audiences with opposite needs on the same platform: a patient looking for plain-language information, a clinician looking for evidence, and a buyer looking for a reference number.
These sites fail on task, not on aesthetics. A prescriber cannot find prescribing information in three clicks, a buyer cannot filter by presentation, a patient lands on content written for a specialist. Each of those is an interface decision, and none of them is fixed by a visual refresh.
Task definition per audience, interface architecture, interactive prototypes tested with real content, a component system with defined states, and the specification developers build from.
We test tasks, not medical behaviour, and keep the usability work clearly scoped so it complements clinical or patient research rather than being mistaken for it.
The variation pharmaceutical UX/UI design has had to hold in one interface.
Design starts from the task, and the task is different for each audience. Pharmaceutical UX/UI design begins there.
What comes up when the interface is the problem.
Where the client can provide access, yes, and it is well worth arranging for the insight it gives. Where they cannot, we test with participants matched on the relevant behaviour and clinical context, and we are explicit about that limitation rather than presenting the results as full clinical validation.
Yes, and in that case we deliver a full specification and component system rather than flat screens alone. We prefer designing and building together, because that is where structural decisions tend to survive contact with real content, but a design-only engagement works well when your development team is already in place.
By resolving it in the architecture rather than at the door. A disclaimer asking someone to confirm they are a professional is a legal device, not an interface solution. The structure itself should make the separation legible before anyone has to declare anything.
No. Brand guidelines govern the visual layer, while almost everything that makes complex interfaces fail sits underneath it — in structure, hierarchy and task flow rather than colour or typography. There is normally considerable room to improve those foundations without touching the visual identity at all.
UX work usually arrives with a redesign or a portal project attached. These are the services it most often sits with.
An interface people cannot complete a task in, or a new platform where the audiences conflict. Tell us who it is for and we will tell you how we would approach the pharmaceutical UX/UI design.